Replies to post #35247 on Revive Therapeutics Ltd (RVVTF)

[tripmcneely]

Do you think 100 patients at high risk is sufficient for the FDA? Seems too small a sample size. Plus we know how slow revive moves. Getting to 1,000 could take them a year to enroll. “Time kills all deals”

Not to mention the cash burn.